ATXS vs VNO · rev $706.0K vs rev $921.3M
Astria Therapeutics Inc (ATXS) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
ATXS currently screens at market cap $382.1M. VNO currently screens at market cap $0.
Not investment advice. Open the ATXS and VNO stock pages for the full models.
Not investment advice.